Adherence With Allergen Immunotherapy Labeling Guidelines

被引:2
作者
Karam, Marilyn [1 ]
Samuels, Kiela [1 ,2 ]
Holland, Christine [1 ]
Hernandez, Cynthia [3 ]
Greenhawt, Matthew [1 ,4 ]
机构
[1] Univ Michigan Hlth Syst, Dept Internal Med, Div Allergy & Clin Immunol, Ann Arbor, MI USA
[2] Univ Michigan, Sch Pharm, Ann Arbor, MI 48106 USA
[3] Univ Michigan, Univ Hlth Serv, Ann Arbor, MI 48106 USA
[4] Univ Michigan, Sch Med, Child Hlth Evaluat & Res Unit, Div Gen Pediat,Dept Pediat, Ann Arbor, MI 48106 USA
关键词
Allergen immunotherapy; Practice parameters; Practice guidelines; Immunotherapy labeling; Allergen extracts; Student health services; Adherence; Health services research; INJECTIONS; MANAGEMENT;
D O I
10.1016/j.jaip.2014.08.012
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
BACKGROUND: Little is known about the adherence rate to allergen immunotherapy (AIT) labeling guidelines. OBJECTIVE: To assess adherence to labeling guidelines of AIT Practice Parameter 2011 at University of Michigan Health Service. METHODS: AIT vials of 320 patients who received their care at the University of Michigan Health Service were reviewed. Data collected looked at patient identifiers (PI), concentrations in volume/volume (v/v) format, color coding, allergen content, expiration date and instructions about AIT dosing, and systemic reaction treatment. Data were analyzed by using chi(2) test and the Fisher exact test and logistic regression. RESULTS: Of 238 non-university formulated labels, 65% had 2 PIs, 62% had a v/v concentration, 41% had color coding, 71% had the content listed, and 100% had a recorded expiration date. Only 21% had all 5 recommended components. All 82 University vials had 5 components. Labels with 2 PIs were more likely to have a v/v concentration with its corresponding color coding (odds ratio [OR] 3.84 [95% CI, 1.9-7.7]; P < .001). Labels that specified the extract's content were more likely to be color coded or to have a v/v concentration listed (OR 6.3 [95% CI, 3.4-11.8]; P < .001). For all AIT vials, complete labels were significantly more likely to have a clear buildup schedule (OR 9.6 [95% CI, 4.2-23.2]; P < .001), dosing adjustment after a missed dose (OR 8.2 [95% CI, 3.4-19.8]; P < .001) or after a reaction (OR 13.7 [95% CI, 7.8-2.1]; P < .001), and clear systemic reaction treatment instructions (OR 9.7 [95% CI, 7.8-24.1]; P < .001). CONCLUSION: Fewer than 25% of the nonuniversity prescribers adhered to AIT practice parameters 5 years after publication. Recording 2 PIs, the v/v concentration, or the color coding increased the likelihood of having a complete label. Complete label contents were associated with clear instructions about AIT dosing and reaction treatment and/or dose adjustments. (C) 2014 American Academy of Allergy, Asthma & Immunology
引用
收藏
页码:250 / 255
页数:6
相关论文
共 19 条
  • [1] Incorrect allergy injections: Allergists' experiences and recommendations for prevention
    Aaronson, DW
    Gandhi, TK
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2004, 113 (06) : 1117 - 1121
  • [2] [Anonymous], 2011, J ALLERGY CLIN IM S1, DOI DOI 10.1016/J.JACI.2010.09.034
  • [3] Twelve-year survey of fatal reactions to allergen injections and skin testing: 1990-2001
    Bernstein, DI
    Wanner, M
    Borish, L
    Liss, GM
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2004, 113 (06) : 1129 - 1136
  • [4] Why don't physicians follow clinical practice guidelines? A framewouk for improvement
    Cabana, MD
    Rand, CS
    Powe, NR
    Wu, AW
    Wilson, MH
    Abboud, PAC
    Rubin, HR
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (15): : 1458 - 1465
  • [5] Variations in management of common inpatient pediatric illnesses: Hospitalists and community pediatricians
    Conway, Patrick H.
    Edwards, Sarah
    Stucky, Erin R.
    Chiang, Vincent W.
    Ottolini, Mary C.
    Landrigan, Christopher P.
    [J]. PEDIATRICS, 2006, 118 (02) : 441 - 447
  • [6] Allergen immunotherapy: A practice parameter second update
    Cox, Linda
    Li, James T.
    Nelson, Harold
    Lockey, Richard
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 120 (03) : S25 - S85
  • [7] Allergen immunotherapy: A practice parameter third update
    Cox, Linda
    Nelson, Harold
    Lockey, Richard
    Calabria, Christopher
    Chacko, Thomas
    Finegold, Ira
    Nelson, Michael
    Weber, Richard
    Bernstein, David I.
    Blessing-Moore, Joann
    Khan, David A.
    Lang, David M.
    Nicklas, Richard A.
    Oppenheimer, John
    Portnoy, Jay M.
    Randolph, Christopher
    Schuller, Diane E.
    Spector, Sheldon L.
    Tilles, Stephen
    Wallace, Dana
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 127 (01) : S1 - S55
  • [8] Allergen immunotherapy practice in the United States: guidelines, measures, and outcomes
    Cox, Linda
    Esch, Robert E.
    Corbett, Mark
    Hankin, Cheryl
    Nelson, Michael
    Plunkett, Greg
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2011, 107 (04) : 289 - 300
  • [9] Immunotherapy Preparation Guidelines, Rules, and Regulation
    Esch, Robert E.
    Plunkett, Greg A.
    [J]. CURRENT ALLERGY AND ASTHMA REPORTS, 2013, 13 (04) : 406 - 413
  • [10] Physician Compliance with Updated Practice Parameters for Influenza Vaccination in Individuals with Egg Allergies
    Greenhawt, Matthew
    Wang, Julie
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2013, 1 (06) : 602 - 607